Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging.

Autor: Buchinskaya NV; Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Isupova EA; Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Vechkasova AO; Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Malekov DA; Radiology Department, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Ivanov DO; Neonatology Department, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Kostik MM; Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 19; Vol. 10, pp. 1252704. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2023).